CTNNB1 and plasma cell myeloma: In the case of multiple myeloma, the AA-genotype of the CTNNB1 gene (that encodes for catenin beta 1) correlated with an increased response to dexamethasone, cyclophosphamide, and thalidomide treatment in comparison with GG and AG genotypes [52].